Skip to main content
Caplight Logo









Empatica

Empatica

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://www.empatica.com/

Last Round

Series B

Nov 22, 2022

Total Funding Raised

$8.33M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Empatica is a health technology company that develops medical-grade wearable devices and AI-powered software platforms for continuous health monitoring, clinical research, and digital biomarker development.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT, Medical AI, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

medical-grade wearableremote patient monitoringRPMdigital biomarkersclinical trial monitoringseizure detectionactigraphywearable health techdecentralized clinical trialsDCTphysiological monitoringhealth IoTmedical AIdigital healthclinical grade wearable

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Empatica Comparables

Compare Empatica with similar companies based on industry and business-model similarity.

Empatica comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Biofourmis
85%
Activinsights
79%
Beacon Biosignals
78%

Empatica Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BNov 22, 2022
GrantNov 6, 2020
GrantJun 18, 2020
GrantMar 31, 2018
Series AApr 1, 2017
Series A
Dec 28, 2016

Key People

Founding team and executive leadership

Simone Tognetti

CTO & co-founder

Founding Team

Matteo Lai

Co-founder And CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 3, 2026

    Acquired PKG Health to expand neurology capabilities.

  • Jan 1, 2026

    Customers include NASA and Harvard University.

Empatica Filings

Explore SEC and related filing metadata, where available.

Empatica filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Empatica's valuation, stock price, and market status.

Is Empatica a public or private company?

Empatica is a private company.

What is the current stock price of Empatica?

Empatica is a private company with no public stock price. No recent secondary market data is available.

How much is Empatica worth (valuation)?

Valuation information for Empatica is not publicly available.

Can I buy Empatica stock?

Empatica shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Empatica's last funding round?

Empatica's most recent funding round was Series B on November 22, 2022.

Who are the main investors in Empatica?

Key investors in Empatica include RA Capital Management, Sanofi Ventures.

Will Empatica IPO soon?

No public IPO plans have been announced for Empatica.

How can I track Empatica secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Empatica's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range107
Year Founded2011
Last FundingNov 22, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?